Literature DB >> 12732649

Yeast frataxin sequentially chaperones and stores iron by coupling protein assembly with iron oxidation.

Sungjo Park1, Oleksandr Gakh, Heather A O'Neill, Arianna Mangravita, Helen Nichol, Gloria C Ferreira, Grazia Isaya.   

Abstract

We have investigated the mechanism of frataxin, a conserved mitochondrial protein involved in iron metabolism and neurodegenerative disease. Previous studies revealed that the yeast frataxin homologue (mYfh1p) is activated by Fe(II) in the presence of O2 and assembles stepwise into a 48-subunit multimer (alpha48) that sequesters >2000 atoms of iron in 2-4-nm cores structurally similar to ferritin iron cores. Here we show that mYfh1p assembly is driven by two sequential iron oxidation reactions: A ferroxidase reaction catalyzed by mYfh1p induces the first assembly step (alpha --> alpha3), followed by a slower autoxidation reaction that promotes the assembly of higher order oligomers yielding alpha48. Depending on the ionic environment, stepwise assembly is associated with accumulation of 50-75 Fe(II)/subunit. Initially, this Fe(II) is loosely bound to mYfh1p and can be readily mobilized by chelators or made available to the mitochondrial enzyme ferrochelatase to synthesize heme. Transfer of mYfh1p-bound Fe(II) to ferrochelatase occurs in the presence of citrate, a physiologic ferrous iron chelator, suggesting that the transfer involves an intermolecular interaction. If mYfh1p-bound Fe(II) is not transferred to a ligand, iron oxidation, and mineralization proceed to completion, Fe(III) becomes progressively less accessible, and a stable iron-protein complex is formed. Iron oxidation-driven stepwise assembly is a novel mechanism by which yeast frataxin can function as an iron chaperone or an iron store.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12732649     DOI: 10.1074/jbc.M303158200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

Review 1.  Friedreich ataxia-update on pathogenesis and possible therapies.

Authors:  Max Voncken; Panos Ioannou; Martin B Delatycki
Journal:  Neurogenetics       Date:  2003-12-19       Impact factor: 2.660

Review 2.  Ferritins: iron/oxygen biominerals in protein nanocages.

Authors:  Elizabeth C Theil; Manolis Matzapetakis; Xiaofeng Liu
Journal:  J Biol Inorg Chem       Date:  2006-07-26       Impact factor: 3.358

3.  Salmonella enterica strains lacking the frataxin homolog CyaY show defects in Fe-S cluster metabolism in vivo.

Authors:  E Vivas; E Skovran; D M Downs
Journal:  J Bacteriol       Date:  2006-02       Impact factor: 3.490

4.  Yeast frataxin solution structure, iron binding, and ferrochelatase interaction.

Authors:  Yanan He; Steven L Alam; Simona V Proteasa; Yan Zhang; Emmanuel Lesuisse; Andrew Dancis; Timothy L Stemmler
Journal:  Biochemistry       Date:  2004-12-28       Impact factor: 3.162

5.  Evaluation of an FRDA-EGFP genomic reporter assay in transgenic mice.

Authors:  Joseph P Sarsero; Timothy P Holloway; Lingli Li; Samuel McLenachan; Kerry J Fowler; Ivan Bertoncello; Lucille Voullaire; Sophie Gazeas; Panos A Ioannou
Journal:  Mamm Genome       Date:  2005-04       Impact factor: 2.957

6.  Chelatases: distort to select?

Authors:  Salam Al-Karadaghi; Ricardo Franco; Mats Hansson; John A Shelnutt; Grazia Isaya; Gloria C Ferreira
Journal:  Trends Biochem Sci       Date:  2006-02-15       Impact factor: 13.807

Review 7.  Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments.

Authors:  Ngolela E Babady; Nadege Carelle; Robert D Wells; Tracey A Rouault; Michio Hirano; David R Lynch; Martin B Delatycki; Robert B Wilson; Grazia Isaya; Hélène Puccio
Journal:  Mol Genet Metab       Date:  2007-06-26       Impact factor: 4.797

8.  Human frataxin: iron and ferrochelatase binding surface.

Authors:  Krisztina Z Bencze; Taejin Yoon; César Millán-Pacheco; Patrick B Bradley; Nina Pastor; J A Cowan; Timothy L Stemmler
Journal:  Chem Commun (Camb)       Date:  2007-03-28       Impact factor: 6.222

9.  PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia.

Authors:  Daniele Marmolino; Mario Manto; Fabio Acquaviva; Paola Vergara; Ajay Ravella; Antonella Monticelli; Massimo Pandolfo
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

Review 10.  The pathogenesis of Friedreich ataxia and the structure and function of frataxin.

Authors:  Massimo Pandolfo; Annalisa Pastore
Journal:  J Neurol       Date:  2009-03       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.